Smith+Nephew Launches FLOW FLEXTEND COBLATION Wand
London, UK, August 17, 2026 Smith+Nephew, a global medical technology company, has announced the launch of its new FLOW...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
London, UK, August 17, 2026 Smith+Nephew, a global medical technology company, has announced the launch of its new FLOW...
LONDON, United Kingdom, July 29, 2026 Smith+Nephew has achieved a significant regulatory milestone after receiving U.S. Food and Drug...
MEQUON, Wis., July 7, 2026 Vector Science & Therapeutics Corp. has entered into a landmark exclusive licensing and cGMP...
BOSTON, Massachusetts, USA – June 9, 2026 Novanta Inc. has announced a definitive agreement to acquire Riverpoint Medical in...
New York, USA – May 20, 2026 Enhanced Group, Inc. announced a major update from its Institutional Review Board...
YOKOHAMA, Japan, May 7, 2026 CoreTissue BioEngineering announced the initiation of the randomized controlled cohort in its ongoing clinical...
UNITED STATES | January 27, 2026 — ABANZA, a medical technology company focused on advancing soft-tissue fixation solutions, announced...
